roma pharmaceuticals limited

Live YoungMidRapid

roma pharmaceuticals limited Company Information

Share ROMA PHARMACEUTICALS LIMITED

Company Number

10217518

Shareholders

mark cresswell

roland alexander brown

View All

Group Structure

View All

Industry

Manufacture of pharmaceutical preparations

 

Registered Address

ground floor, gibraltar house, crown square, first avenue, burton-on-trent, DE14 2WE

roma pharmaceuticals limited Estimated Valuation

£7.6m

Pomanda estimates the enterprise value of ROMA PHARMACEUTICALS LIMITED at £7.6m based on a Turnover of £5.3m and 1.42x industry multiple (adjusted for size and gross margin).

roma pharmaceuticals limited Estimated Valuation

£7.5m

Pomanda estimates the enterprise value of ROMA PHARMACEUTICALS LIMITED at £7.5m based on an EBITDA of £1.3m and a 5.9x industry multiple (adjusted for size and gross margin).

roma pharmaceuticals limited Estimated Valuation

£0

Pomanda estimates the enterprise value of ROMA PHARMACEUTICALS LIMITED at £0 based on Net Assets of £-1.5m and 2.07x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Roma Pharmaceuticals Limited Overview

Roma Pharmaceuticals Limited is a live company located in burton-on-trent, DE14 2WE with a Companies House number of 10217518. It operates in the manufacture of pharmaceutical preparations sector, SIC Code 21200. Founded in June 2016, it's largest shareholder is mark cresswell with a 45.9% stake. Roma Pharmaceuticals Limited is a young, mid sized company, Pomanda has estimated its turnover at £5.3m with rapid growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Roma Pharmaceuticals Limited Health Check

Pomanda's financial health check has awarded Roma Pharmaceuticals Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4out of 5
positive_score

4 Strong

positive_score

3 Regular

positive_score

5 Weak

size

Size

annual sales of £5.3m, make it smaller than the average company (£36m)

£5.3m - Roma Pharmaceuticals Limited

£36m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 79%, show it is growing at a faster rate (3.8%)

79% - Roma Pharmaceuticals Limited

3.8% - Industry AVG

production

Production

with a gross margin of 31%, this company has a comparable cost of product (31%)

31% - Roma Pharmaceuticals Limited

31% - Industry AVG

profitability

Profitability

an operating margin of 23.7% make it more profitable than the average company (8.4%)

23.7% - Roma Pharmaceuticals Limited

8.4% - Industry AVG

employees

Employees

with 8 employees, this is below the industry average (93)

8 - Roma Pharmaceuticals Limited

93 - Industry AVG

paystructure

Pay Structure

on an average salary of £67.9k, the company has an equivalent pay structure (£67.9k)

£67.9k - Roma Pharmaceuticals Limited

£67.9k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £665.6k, this is more efficient (£373.3k)

£665.6k - Roma Pharmaceuticals Limited

£373.3k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 75 days, this is later than average (46 days)

75 days - Roma Pharmaceuticals Limited

46 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 67 days, this is slower than average (35 days)

67 days - Roma Pharmaceuticals Limited

35 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 110 days, this is in line with average (115 days)

110 days - Roma Pharmaceuticals Limited

115 days - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 7 weeks, this is less cash available to meet short term requirements (10 weeks)

7 weeks - Roma Pharmaceuticals Limited

10 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 146.3%, this is a higher level of debt than the average (44.3%)

146.3% - Roma Pharmaceuticals Limited

44.3% - Industry AVG

ROMA PHARMACEUTICALS LIMITED financials

EXPORTms excel logo

Roma Pharmaceuticals Limited's latest turnover from June 2024 is estimated at £5.3 million and the company has net assets of -£1.5 million. According to their latest financial statements, Roma Pharmaceuticals Limited has 8 employees and maintains cash reserves of £704.6 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Turnover5,324,9803,621,8681,919,996926,290526,335592,1563,521,7822,579,723
Other Income Or Grants00000000
Cost Of Sales3,674,4002,356,7941,236,960580,996325,275338,2541,961,3801,398,454
Gross Profit1,650,5801,265,073683,036345,294201,060253,9011,560,4021,181,269
Admin Expenses387,912524,9061,160,931564,646457,9751,239,5372,478,1291,324,187
Operating Profit1,262,668740,167-477,895-219,352-256,915-985,636-917,727-142,918
Interest Payable00000000
Interest Receivable26,63510,8673,1343313481,54100
Pre-Tax Profit1,289,303751,033-474,761-219,021-256,567-984,095-917,727-142,918
Tax-322,326-187,758000000
Profit After Tax966,977563,275-474,761-219,021-256,567-984,095-917,727-142,918
Dividends Paid00000000
Retained Profit966,977563,275-474,761-219,021-256,567-984,095-917,727-142,918
Employee Costs543,501448,968428,578349,005221,268119,730103,11998,924
Number Of Employees87764222
EBITDA*1,268,382747,226-467,976-212,894-253,208-985,636-917,727-142,918

* Earnings Before Interest, Tax, Depreciation and Amortisation

Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Tangible Assets6,4988,29312,81620,62012,468000
Intangible Assets00000000
Investments & Other00000000
Debtors (Due After 1 year)00000000
Total Fixed Assets6,4988,29312,81620,62012,468000
Stock & work in progress1,109,016695,138448,504180,4820000
Trade Debtors1,106,966905,628353,72392,98039,5750473,433871,358
Group Debtors00000000
Misc Debtors207,205232,971339,350223,209139,28796,02900
Cash704,550310,122124,551376,833284,868410,87500
misc current assets00000000
total current assets3,127,7372,143,8591,266,128873,504463,730506,904473,433871,358
total assets3,134,2352,152,1521,278,944894,124476,198506,904473,433871,358
Bank overdraft00000000
Bank loan00000000
Trade Creditors 683,513551,946340,642173,7969,89001,532,5781,500
Group/Directors Accounts00000001,012,776
other short term finances00000000
hp & lease commitments00000000
other current liabilities3,901,0744,031,9253,933,2963,240,5612,767,5452,551,57400
total current liabilities4,584,5874,583,8714,273,9383,414,3572,777,4352,551,5741,532,5781,014,276
loans00000000
hp & lease commitments00000000
Accruals and Deferred Income0000001,5000
other liabilities00000000
provisions00000000
total long term liabilities0000001,5000
total liabilities4,584,5874,583,8714,273,9383,414,3572,777,4352,551,5741,534,0781,014,276
net assets-1,450,352-2,431,719-2,994,994-2,520,233-2,301,237-2,044,670-1,060,645-142,918
total shareholders funds-1,450,352-2,431,719-2,994,994-2,520,233-2,301,237-2,044,670-1,060,645-142,918
Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Jun 2019Jun 2018Jun 2017
Operating Activities
Operating Profit1,262,668740,167-477,895-219,352-256,915-985,636-917,727-142,918
Depreciation5,7147,0599,9196,4583,707000
Amortisation00000000
Tax-322,326-187,758000000
Stock413,878246,634268,022180,4820000
Debtors175,572445,526376,884137,32782,833-377,404-397,925871,358
Creditors131,567211,304166,846163,9069,890-1,532,5781,531,0781,500
Accruals and Deferred Income-130,85198,629692,735473,016215,9712,550,0741,5000
Deferred Taxes & Provisions00000000
Cash flow from operations357,322177,241-253,301106,219-110,180409,2641,012,776-1,012,776
Investing Activities
capital expenditure-3,919-2,536-2,115-14,610-16,175000
Change in Investments00000000
cash flow from investments-3,919-2,536-2,115-14,610-16,175000
Financing Activities
Bank loans00000000
Group/Directors Accounts000000-1,012,7761,012,776
Other Short Term Loans 00000000
Long term loans00000000
Hire Purchase and Lease Commitments00000000
other long term liabilities00000000
share issue14,390002507000
interest26,63510,8673,1343313481,54100
cash flow from financing41,02510,8673,1343563481,611-1,012,7761,012,776
cash and cash equivalents
cash394,428185,571-252,28291,965-126,007410,87500
overdraft00000000
change in cash394,428185,571-252,28291,965-126,007410,87500

roma pharmaceuticals limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for roma pharmaceuticals limited. Get real-time insights into roma pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Roma Pharmaceuticals Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for roma pharmaceuticals limited by selecting its closest rivals, whether from the MANUFACTURING sector, other mid companies, companies in DE14 area or any other competitors across 12 key performance metrics.

roma pharmaceuticals limited Ownership

ROMA PHARMACEUTICALS LIMITED group structure

Roma Pharmaceuticals Limited has no subsidiary companies.

Ultimate parent company

ROMA PHARMACEUTICALS LIMITED

10217518

ROMA PHARMACEUTICALS LIMITED Shareholders

mark cresswell 45.92%
roland alexander brown 45.92%
philip john wright 5.1%
lucy walley 3.06%

roma pharmaceuticals limited directors

Roma Pharmaceuticals Limited currently has 4 directors. The longest serving directors include Mr Mark Cresswell (Jun 2016) and Mr Roland Brown (Jun 2016).

officercountryagestartendrole
Mr Mark CresswellEngland57 years Jun 2016- Director
Mr Roland BrownEngland53 years Jun 2016- Director
Mr Philip WrightEngland59 years Jun 2020- Director
Ms Lucy WalleyEngland44 years Jun 2024- Director

P&L

June 2024

turnover

5.3m

+47%

operating profit

1.3m

0%

gross margin

31%

-11.26%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2024

net assets

-1.5m

-0.4%

total assets

3.1m

+0.46%

cash

704.6k

+1.27%

net assets

Total assets minus all liabilities

roma pharmaceuticals limited company details

company number

10217518

Type

Private limited with Share Capital

industry

21200 - Manufacture of pharmaceutical preparations

incorporation date

June 2016

age

9

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

June 2024

previous names

N/A

accountant

ATRAXA CONSULTING LIMITED

auditor

-

address

ground floor, gibraltar house, crown square, first avenue, burton-on-trent, DE14 2WE

Bank

-

Legal Advisor

-

roma pharmaceuticals limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to roma pharmaceuticals limited. Currently there are 1 open charges and 1 have been satisfied in the past.

roma pharmaceuticals limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ROMA PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.

roma pharmaceuticals limited Companies House Filings - See Documents

datedescriptionview/download